SN-2
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H21NO |
| Molar mass | 255.361 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
SN-2 is a chemical compound which acts as an "agonist" (i.e. channel opener) for the TRPML3 calcium channel, with high selectivity for TRPML3 and no significant activity at the related TRPML1 and TRPML2 channels.[1] It has demonstrated antiviral activity in an in vitro model.[2]
See also
[edit]References
[edit]- ↑ Grimm C, Jörs S, Saldanha SA, Obukhov AG, Pan B, Oshima K, et al. (February 2010). "Small molecule activators of TRPML3". Chemistry & Biology. 17 (2): 135–48. doi:10.1016/j.chembiol.2009.12.016. PMC 2834294. PMID 20189104.
- ↑ Xia Z, Wang L, Li S, Tang W, Sun F, Wu Y, et al. (October 2020). "ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity". Antiviral Research. 182 104922. doi:10.1016/j.antiviral.2020.104922. PMID 32858116. S2CID 221365410.
 | This antiinfective drug article is a stub. You can help Wikipedia by adding missing information. |